Xiaoyan Zhan

Years Active: 2021-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Jia Zhao, Hongbin Liu, Zhixian Hong, Wei Luo, Wenqing Mu, Xiaorong Hou, Guang Xu, Zhie Fang, Lutong Ren, Tingting Liu, Jincai Wen, Wei Shi, Ziying Wei, Yongping Yang, Wenjun Zou, Jun Zhao, Xiaohe Xiao, Zhaofang Bai, Xiaoyan Zhan
Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Qiang Li, Hui Feng, Hongbo Wang, Yinghao Wang, Wenqing Mou, Guang Xu, Ping Zhang, Ruisheng Li, Wei Shi, Zhilei Wang, Zhie Fang, Lutong Ren, Yan Wang, Li Lin, Xiaorong Hou, Wenzhang Dai, Zhiyong Li, Ziying Wei, Tingting Liu, Jiabo Wang, Yuming Guo, Pengyan Li, Xu Zhao, Xiaoyan Zhan, Xiaohe Xiao, Zhaofang Bai
Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7-NLRP3 interaction. EMBO reports (2021)

Xiaoyan Zhan.css-eqlu8i{font-size:small;padding-left:4px;}